COLUMBUS, Ohio – Chris Bradley shared an update on his recovery Monday night on social media.
In a Facebook post, Chris said he is going to start new clinical trial medication at the Ohio State University James Cancer Center for his specific type of leukemia. He was diagnosed with acute myeloid leukemia in March.
Chris said he is hopeful the medication can get him back into remission.
He also shared that his original bone marrow donor is back on the bone registry and can help him after not being able to donate over the summer.
He said when he gets back into remission, the plan is to move forward with a bone marrow transplant.
